Fernando F. Blanco, Ph.D.
|2012||Biomedical Science||University of South Carolina, Columbia, SC|
Area:Oncology, Molecular Biology, Biochemistry
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Blanco FF, Preet R, Aguado A, et al. (2016) Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis. Oncotarget|
|Sobolewski C, Sanduja S, Blanco FF, et al. (2015) Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. Biomolecules. 5: 2035-55|
|Piasecka-Srader J, Blanco FF, Delman DH, et al. (2015) Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries. Biology of Reproduction. 92: 132|
|Blanco FF, Sanduja S, Deane NG, et al. (2014) Transforming growth factor β regulates P-body formation through induction of the mRNA decay factor tristetraprolin. Molecular and Cellular Biology. 34: 180-95|
|Dixon DA, Blanco FF, Bruno A, et al. (2013) Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 191: 7-37|
|Sanduja S, Blanco FF, Young LE, et al. (2012) The role of tristetraprolin in cancer and inflammation. Frontiers in Bioscience (Landmark Edition). 17: 174-88|
|Sanduja S, Blanco FF, Dixon DA. (2011) The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdisciplinary Reviews. Rna. 2: 42-57|